A focus on the association of Apol1 with kidney disease in children

被引：12

作者：

Ekulu, Pepe M. ^{[1
,2
]}

Nkoy, Agathe B. ^{[2
]}

Adebayo, Oyindamola C. ^{[1
]}

Kazadi, Orly K. ^{[2
]}

Aloni, Michel N. ^{[2
]}

Arcolino, Fanny O. ^{[1
]}

Ngiyulu, Rene M. ^{[2
]}

Gini, Jean-Lambert E. ^{[2
]}

Lepira, Francois B. ^{[3
]}

van den Heuvel, Lamberthus P. ^{[1
,4
]}

Levtchenko, Elena N. ^{[5
,6
]}

机构：

[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium

[2] Univ Kinshasa, Div Nephrol, Dept Pediat, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO

[3] Univ Kinshasa, Div Nephrol, Dept Internal Med, Fac Med,Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO

[4] Radboud Univ Nijmegen, Dept Pediat Nephrol, Med Ctr, Nijmegen, Netherlands

[5] Katholieke Univ Leuven, Dept Pediat Nephrol, Univ Hosp Leuven, Leuven, Belgium

[6] Katholieke Univ Leuven, Dept Dev & Regenerat, Univ Hosp Leuven, Leuven, Belgium

来源：

PEDIATRIC NEPHROLOGY | 2021年 / 36卷 / 04期

关键词：

APOL1; Chronic kidney disease; Children; Genetics; Sickle cell disease; HIV-associated nephropathy; STAGE RENAL-DISEASE; AFRICAN-AMERICAN CHILDREN; RISK VARIANTS; APOLIPOPROTEIN L1; NEPHROPATHY; GENE; GENOTYPE; OUTCOMES; ALLELES; ADULTS;

D O I：

10.1007/s00467-020-04553-z

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Individuals of African origin have an increased risk of developing various progressive chronic kidney diseases (CKD). This risk has been attributed to genetic variants (G1, G2) in apolipoprotein-L1 (APOL1) gene. In the pediatric population, especially in children affected by sickle cell disease (SCD), by human immunodeficiency virus (HIV), or with various glomerular diseases, APOL1 risk variants have been associated with the development of hypertension, albuminuria, and more rapid decline of kidney function. The present review focuses on existing APOL1-related epidemiological data in children with CKD. It also includes data from studies addressing racial disparities in CKD, the APOL1-related innate immunity, and the relationship between APOL1 and CKD and pathogenic pathways mediating APOL1-related kidney injury.

引用

页码：777 / 788

页数：12

共 50 条

[41] APOL1 Kidney Risk Variants and Proteomics
Chen, Teresa K.
Surapaneni, Aditya L.
Arking, Dan E.
Ballantyne, Christie M.
Boerwinkle, Eric
Chen, Jingsha
Coresh, Josef
Koettgen, Anna
Susztak, Katalin
Tin, Adrienne
Yu, Bing
Grams, Morgan E.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (05): : 684 - 692
[42] Population genetics of chronic kidney disease: The evolving story of APOL1
Wasser, Walter G.
Tzur, Shay
Wolday, Dawit
Adu, Dwomoa
Baumstein, Donald
Rosset, Saharon
Skorecki, Karl
JOURNAL OF NEPHROLOGY, 2012, 25 (05) : 603 - 618
[43] APOL1 variants and kidney disease in people of recent African ancestry
Genovese, Giulio
Friedman, David J.
Pollak, Martin R.
NATURE REVIEWS NEPHROLOGY, 2013, 9 (04) : 240 - 244
[44] APOL1 Variants From Parasites to Kidney Function to Cardiovascular Disease
Reiner, Alex P.
Susztak, Katalin
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (02) : 219 - 220
[45] APOL1 and Kidney Disease: New Insights Leading to Novel Therapies
Freedman, Barry I.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (01) : 9 - 11
[46] APOL1 variants and kidney disease. There is no such thing as a free lunch
Kronenberg, Florian
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (03) : 775 - 778
[47] APOL1 Risk Variants, Race, and Progression of Chronic Kidney Disease
Parsa, Afshin
Kao, W. H. Linda
Xie, Dawei
Astor, Brad C.
Li, Man
Hsu, Chi-yuan
Feldman, Harold I.
Parekh, Rulan S.
Kusek, John W.
Greene, Tom H.
Fink, Jeffrey C.
Anderson, Amanda H.
Choi, Michael J.
Wright, Jackson T., Jr.
Lash, James P.
Freedman, Barry I.
Ojo, Akinlolu
Winkler, Cheryl A.
Raj, Dominic S.
Kopp, Jeffrey B.
He, Jiang
Jensvold, Nancy G.
Tao, Kaixiang
Lipkowitz, Michael S.
Appel, Lawrence J.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (23): : 2183 - 2196
[48] APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults
Mukamal, Kenneth J.
Tremaglio, Joseph
Friedman, David J.
Ix, Joachim H.
Kuller, Lewis H.
Tracy, Russell P.
Pollak, Martin R.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (02) : 398 - 403
[49] APOL1 INHIBITION BY VX-147 AS A TARGETED THERAPY FOR APOL1-MEDIATED KIDNEY DISEASE
Pollak, Martin
Friedman, David
Barisoni, Laura
Falk, Ronald
Gipson, Debbie
Lipkowitz, Michael
Ojo, Akinlolu
Chirieac, Madalina
Xu, Cong
Fortier, Anne
Egbuna, Ogo
Bunnage, Mark
Chertow, Glenn
AMERICAN JOURNAL OF KIDNEY DISEASES, 2022, 79 (05) : 769 - 769
[50] APOL1 Expression Does Not Vary With Disease State in Patients with ApoL1 Risk Alleles
Caza, Tiffany
Wilson, Jon
Larsen, Chris
MODERN PATHOLOGY, 2019, 32

← 1 2 3 4 5 →